Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Jaguar Health stock

Own Jaguar Health stock in just a few minutes.


Fact checked

Jaguar Health, Inc is a biotechnology business based in the US. Jaguar Health shares (JAGX) are listed on the NASDAQ and all prices are listed in US Dollars. Jaguar Health employs 29 staff and has a trailing 12-month revenue of around USD$6.5 million.

How to buy shares in Jaguar Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Jaguar Health. Find the stock by name or ticker symbol: JAGX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Jaguar Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Jaguar Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Jaguar Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Jaguar Health share price

Use our graph to track the performance of JAGX stocks over time.

Jaguar Health shares at a glance

Information last updated 2020-10-20.
52-week range USD$0.284 - USD$0.96
50-day moving average USD$0.3362
200-day moving average USD$0.4886
Wall St. target price USD$5
PE ratio 0.0157
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-79.453

Buy Jaguar Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Jaguar Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Jaguar Health under- or over-valued?

Valuing Jaguar Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Jaguar Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Jaguar Health's P/E ratio

Jaguar Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Jaguar Health shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Jaguar Health financials

Revenue TTM USD$6.5 million
Gross profit TTM USD$-3,782,372
Return on assets TTM -38.14%
Return on equity TTM -310.33%
Profit margin 0%
Book value $0.019
Market capitalisation USD$17.2 million

TTM: trailing 12 months

Shorting Jaguar Health shares

There are currently 380,248 Jaguar Health shares held short by investors – that's known as Jaguar Health's "short interest". This figure is 68.1% down from 1.2 million last month.

There are a few different ways that this level of interest in shorting Jaguar Health shares can be evaluated.

Jaguar Health's "short interest ratio" (SIR)

Jaguar Health's "short interest ratio" (SIR) is the quantity of Jaguar Health shares currently shorted divided by the average quantity of Jaguar Health shares traded daily (recently around 5.4 million). Jaguar Health's SIR currently stands at 0.07. In other words for every 100,000 Jaguar Health shares traded daily on the market, roughly 70 shares are currently held short.

However Jaguar Health's short interest can also be evaluated against the total number of Jaguar Health shares, or, against the total number of tradable Jaguar Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Jaguar Health's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Jaguar Health shares in existence, roughly 10 shares are currently held short) or 0.0078% of the tradable shares (for every 100,000 tradable Jaguar Health shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Jaguar Health.

Find out more about how you can short Jaguar Health stock.

Jaguar Health share dividends

We're not expecting Jaguar Health to pay a dividend over the next 12 months.

Have Jaguar Health's shares ever split?

Jaguar Health's shares were split on a 1:70 basis on 7 June 2019. So if you had owned 70 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Jaguar Health shares – just the quantity. However, indirectly, the new 6900% higher share price could have impacted the market appetite for Jaguar Health shares which in turn could have impacted Jaguar Health's share price.

Jaguar Health share price volatility

Over the last 12 months, Jaguar Health's shares have ranged in value from as little as $0.284 up to $0.96. A popular way to gauge a stock's volatility is its "beta".

JAGX.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Jaguar Health's is 0.9307. This would suggest that Jaguar Health's shares are less volatile than average (for this exchange).

Jaguar Health overview

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. It operates through two reportable segments, Human Health and Animal Health. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its human health product pipelines include crofelemer, which is in Phase III clinical trial for the treatment of cancer therapy-related diarrhea, as well as for the supportive care for inflammatory bowel disease; formulation of crofelemer that is Phase II clinical trial for the treatment of short bowel syndrome, congenital diarrheal disorders, idiopathic/functional diarrhea, and irritable bowel; and SB-300, a second-generation anti-secretory agent for various indications, including cholera. The company's animal health product candidates comprise Canalevia, an animal prescription drug product candidate intended for treatment of chemotherapy-induced diarrhea in dogs; and Equilevia, a non-prescription product for total gut health in equine athletes. In addition, its products include Neonorm Calf and Neonorm Foal. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site